10E.F · Aphria Inc

-

Please sign in to comment on 10E.F

1 Comment

Admin

4 years ago

Aphria Inc is currently in a long term uptrend where the price is trading 37.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.5.

Aphria Inc's total revenue rose by 33.6% to $161M since the same quarter in the previous year.

Its net income has dropped by 1421.0% to $-121M since the same quarter in the previous year.

Finally, its free cash flow grew by 75.7% to $-16M since the same quarter in the previous year.

Based on the above factors, Aphria Inc gets an overall score of 4/5.

ISIN	None
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	F
CurrencyCode	EUR

PE Ratio	None
Target Price	None
Beta	2.62
Dividend Yield	0.0%
Market Cap	3B

ABOUT

Aphria Inc

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

10E.F · Aphria Inc

-

Aphria Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Aphria Inc using a moving average strategy